Articles

Bond yields rise as traders eye tariff developments

Bond yields rose on Friday with investors paying attention to tariff news as key inflation data was set for release.

Why there’s now ‘incredible demand for physical gold’ in New York markets

A rush on physical gold, thanks to President Donald Trump’s tariff threats, has fueled a rise in prices of the precious metal to fresh record highs.

Another wild weekend of headlines is coming. Here’s a trade to make ahead of it.

Investors aren’t sure if President Trump will formally apply import penalties or not

Heavyweight hedge fund Elliott reportedly says Trump administration driving a crypto frenzy

One of the most powerful hedge funds on Wall Street has reportedly criticized the Trump administration for helping drive a frenzy around cryptocurrencies that could ultimately harm investors.

DeepSeek is now available via Amazon Web Services. ‘Have at it,’ says CEO Jassy.

The Chinese AI that has taken the internet by storm is now available for application use through Amazon’s cloud, the U.S. company said.

‘We have no credit-card debt’: I’m getting married for the second time. We’re combining our $500,000 in assets. Is that a good idea?

”I kept my finances totally separate in my first 20-plus year marriage — and I’m going to do it differently this time.”

The bears never stood a chance — this month. But Goldman strategist says he’ll turn ‘tactical bear’ after Valentine’s.

Between you-only-live-once retail traders, big corporates buying back their stock and retirement allocation demand, the bears never stood a chance, says a Goldman Sachs strategist.

Macaulay Culkin sells $7.75 million New York City apartment he bought as a teen—making a nice profit

Property records show that the 5,937-square-foot condo was placed on the market Jan. 10 for $7.75 million and the listing was removed a day later.

Vertex Pharmaceuticals stock is soaring. The FDA just approved its potentially game-changing pain treatment.

Shares of Vertex Pharmaceuticals Inc. surged ahead of Friday’s market open after the Food and Drug Administration approved the company’s non-opioid pain treatment.

How Apple pulled off a major feat that offset its big China miss on iPhones

The real star of the show was Apple’s services business, with revenue growth of 14% and gross margins of 75%.

These ETFs can help investors protect themselves from selloffs like the DeepSeek panic — but here’s the catch

Investors seeking refuge from market volatility may consider buffer ETFs that swap some stock-market gains for downside protection. But make sure you understand the trade-off before jumping in.

The latest step in Walgreens’ turnaround is a blow to investors

Walgreens has struggled as foot traffic at its stores dwindle and pharmacy business faces slimmer reimbursement rates on prescription drugs.
1 642 643 644 645 646 2,511